LifeVantage Corp ( (LFVN) ) has released its Q4 earnings. Here is a breakdown of the information LifeVantage Corp presented to its investors.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
LifeVantage Corporation, a leader in the health and wellness industry, specializes in products that activate optimal health processes at the cellular level, offering a unique approach to nutrigenomics.
In its latest earnings report, LifeVantage announced a strong financial performance for the fourth quarter and full fiscal year 2025. The company reported a notable increase in revenue and net income, highlighting the successful rollout of its MindBody System in international markets and robust growth in the Americas.
Key financial metrics for the fourth quarter included a 12.6% increase in revenue to $55.1 million and a rise in net income per diluted share to $0.15 from $0.10 in the previous year. For the full fiscal year 2025, revenue grew by 14.2% to $228.5 million, with net income per diluted share increasing significantly to $0.75 from $0.23 in fiscal 2024. The company’s adjusted EBITDA also saw a substantial increase of 30.3%, reaching $22.1 million.
Strategically, LifeVantage’s international business returned to growth, particularly in Asia/Pacific and Europe, while the Americas continued to show strong performance. The company repurchased 0.3 million shares for $3.1 million, maintaining a strong balance sheet with $20.2 million in cash and no debt.
Looking ahead, LifeVantage is optimistic about its growth prospects for fiscal 2026, with expectations of generating revenue between $225 million and $240 million and adjusted earnings per share ranging from $1.00 to $1.15. The company aims to leverage its scalable platform for continued growth and long-term value creation.